About ALA
Within the Health Care space, Arovella Therapeutics Ltd (ALA) is a biotechnology business centred on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumours.
All News for ALA
No news articles found for ALA yet.